<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="565218" id="root" date="1997-05-07" xml:lang="en">
<title>USA: Carter-Wallace Q4 shr $0.03 vs $0.02.</title>
<headline>Carter-Wallace Q4 shr $0.03 vs $0.02.</headline>
<dateline>NEW YORK 1997-05-07</dateline>
<text>
<p>SUMMARY OF OPERATING RESULTS</p>
<p>					    THREE MONTHS ENDED</p>
<p>					 Mar 31, 1997     Mar 31, 1996</p>
<p> Sales				 $156,314,000     $165,089,000</p>
<p>Earnings Before One-Time</p>
<p> Charges and Taxes		    2,340,000	  6,985,000</p>
<p> One-Time Charges			  ---	(5,400,000) (b)</p>
<p> Earnings Before Taxes	  2,340,000 (a)	  1,585,000</p>
<p> Net Earnings			   1,381,000	    935,000</p>
<p> Earnings Per Share			  0.03		 0.02</p>
<p> Average Shares Outstanding	46,384,000	 46,220,000</p>
<p>Twelve Months Period</p>
<p> Sales				 $648,755,000    $658,940,000</p>
<p>Earnings Before One-Time</p>
<p> Charges and Taxes		   45,349,000	54,797,000</p>
<p> One-Time Charges			    --    (42,000,000) (b)</p>
<p> Earnings Before Taxes		45,349,000 (a) 12,797,000</p>
<p> Net Earnings			  26,756,000	 7,550,000</p>
<p> Earnings Per Share			  0.58		0.16</p>
<p> Average Shares Outstanding	46,389,000	46,160,000</p>
<p>(a)  The results of operations for the fourth quarter and</p>
<p>year ended March 31, 1997 include introductory spending</p>
<p>related to Astelin nasal spray for seasonal allergic</p>
<p>rhinitis which was launched during the quarter. (b)  In the prior year, the Company incurred one-time</p>
<p>charges related to the closure of its condom</p>
<p>manufacturing plant in Trenton, New Jersey, the</p>
<p>restructuring of operations and facilities and</p>
<p>adjustments of previously established reserves for</p>
<p>Felbatol and Organidin iodinated glycerol.  These one-</p>
<p>time costs resulted in a pre-tax charge of $5,400,000</p>
<p>($3,200,000 after tax or $.07 per share) in the quarter</p>
<p>and a pre-tax charge of $42,000,000 ($24,800,000 after</p>
<p>tax or $.54 per share) for the year ended March 31,</p>
<p>1996.</p>
<p>Carter-Wallace, Inc. markets toiletries, proprietary drugs, pharmaceuticals, diagnostic specialties and pet products.</p>
<p>-- New York Newsdesk 212 859-1610</p>
</text>
<copyright>(c) Reuters Limited 1997</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-07"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-07"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C15">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-07"/>
  </code>
  <code code="C151">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-07"/>
  </code>
  <code code="C1511">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-07"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1997-05-07"/>
  </code>
</codes>
<dc element="dc.date.created" value="1997-05-07"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1997-05-07"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="NEW YORK"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
